Novo Holdings board member steps down after less than two years in role
Carsten Stendevad has chosen to leave Novo Holdings' board as he has been given new investment responsibilities at the world's largest hedge fund, Bridgewater.
by christopher due karlsson, translated by catherine brett
After just under two years in the role of board member at Novo Nordisk fund Novo Holdings, Carsten Stendevad has chosen to step down.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
